(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Vical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in Genital Herpes Lesions Durable to 9 Months

June 20, 2016

Vical plans to advance the bivalent vaccine to a Phase 2 trial in 2016 and maintains current financial guidance for 2016

Vical Reports First Quarter 2016 Financial Results

May 08, 2016

Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months ended March 31, 2016. Net loss for the first quarter of 2016 was $2.4 million, or $0.03 per share, compared with a...

Performance

More News

Investor Calendar Invites You to the Vical First Quarter 2016 Earnings Webcast Live on Monday, May 9, 2016

May 06, 2016

Vical Announces News Release and Conference Call Schedule for First Quarter 2016 Financial Results

May 01, 2016

FDA Grants Vical Fast Track Designation for VL-2397 for the Treatment of Invasive Aspergillosis

March 29, 2016

Vical Reports Fourth Quarter 2015 Financial Results

March 13, 2016

Investor Calendar Invites You to the Vical Fourth Quarter and Fiscal Year 2015 Earnings Webcast Live on Monday, March 14, 2016

March 10, 2016

Vical to Present at the 28th Annual ROTH Conference

March 08, 2016

Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2015 Financial Results

March 07, 2016

Vical Initiates Phase 1 Trial of Novel Antifungal Compound VL-2397

March 06, 2016

FDA Grants Vical Orphan Drug Designation for VL-2397 for the Treatment of Invasive Aspergillosis

January 05, 2016

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.